Kemnay Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Kemnay Advisory Services's BMY Position: Q2 2026 in Review
Kemnay Advisory Services increased its Bristol-Myers Squibb (BMY) stake by 5.1% in Q2 2026, buying an estimated $2.41K and bringing the position to 862 shares worth $49.7K. The position accounts for 0.01% of the portfolio, ranked #303.
Kemnay Advisory Services first reported a position in BMY in Q4 2020 and has held it in 4 quarters since. The position peaked at $765K in Q4 2020. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Kemnay Advisory Services held 862 shares of Bristol-Myers Squibb worth $49.7K as of Q2 2026.
- Kemnay Advisory Services bought 42 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.41K.
- Bristol-Myers Squibb made up 0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #303 holding.
- Kemnay Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 4 quarters since.
- Kemnay Advisory Services's Bristol-Myers Squibb position peaked at $765K in Q4 2020.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.